From phenotypical investigation to RNA-sequencing for gene expression analysis: A workflow for single and pooled rare

Tania Rossi1, Davide Angeli2, Giovanni Martinelli3

  • 1Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.

Frontiers in Genetics
|December 1, 2022
PubMed

Insights

Investigating rare cells like circulating tumor cells (CTCs) is difficult. A new workflow using DEPArray technology enables transcriptomic analysis of single or pooled CTCs after phenotypic characterization.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Characterizing rare cells, such as circulating tumor cells (CTCs), is crucial for understanding cancer metastasis.
  • Existing methods often hinder downstream molecular analysis, particularly RNA studies, due to cell fixation requirements.

Purpose of the Study:

  • To develop and validate an experimental workflow for transcriptomic analysis of rare cells.
  • To enable phenotypic and molecular characterization of single or pooled cells using DEPArray technology.

Main Methods:

  • DEPArray technology was employed for phenotypic analysis and cell recovery.
  • OE33 cells were analyzed under various fixation conditions (unfixed, CellSearch fixative, ethanol).
  • Transcriptomic analysis was performed on single and pooled recovered cells.

Main Results:

  • The described workflow successfully enabled transcriptomic investigation of single and pooled OE33 cells post-DEPArray analysis.
  • The method is applicable to cells processed under different fixation conditions, including unfixed, CSF-fixed, and EtOH-fixed cells.

Conclusions:

  • This workflow facilitates comprehensive characterization of rare cells, combining phenotypic and molecular data.
  • It offers a versatile approach for gene expression profiling of rare cells, supporting future research in cancer biology and diagnostics.